Standpoint Research Starts ANI Pharmaceuticals (ANIP) at Buy
Tweet
Share
E-mailGet Alerts ANIP Hot Sheet
Price: $83.05 +0.33%
Rating Summary:
11 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 11 | New: 25
Rating Summary:
11 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 11 | New: 25
Join SI Premium – FREE
Standpoint Research initiated coverage on ANI Pharmaceuticals (NASDAQ: ANIP) with a Buy rating.
For an analyst ratings summary and ratings history on ANI Pharmaceuticals click here. For more ratings news on ANI Pharmaceuticals click here.
Shares of ANI Pharmaceuticals closed at $40.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Craig-Hallum Starts Fractyl Health Inc (GUTS) at Buy
- Prabhudas Lilladher Starts Acutaas Chemicals (ACUTAAS:IN) at Accumulate (2)
- Baird Starts Abbott Labs (ABT) at Outperform, 'Set to Improve with Catalysts Ahead'
Create E-mail Alert Related Categories
New CoverageRelated Entities
Standpoint ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
